Е. С. Филатова

1.4k citations

51 papers · 128 indexed · h-index 6

Co-authors: А. М. Лила А. Е. Каратеев Л. И. Алексеева Е. Л. Насонов Ш. Ф. Эрдес D Taylor‐Robinson N. Bulanov Dominique P. Germain
Topics: Fibromyalgia and Chronic Fatigue Syndrome Research (15 papers)Rheumatoid Arthritis Research and Therapies (15 papers)Pain Mechanisms and Treatments (13 papers)
Cited by: Anatomy Psychiatry and Mental health Rheumatology
Journals: SHILAP Revista de lepidopterologíaAnnals of the Rheumatic Diseases Genes
Partner nations: Russia Czechia United Kingdom

In The Last Decade

Е. С. Филатова

37 papers receiving 112 citations

Peers

Countries citing papers authored by Е. С. Филатова

Since Specialization

Citations

This map shows the geographic impact of Е. С. Филатова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Е. С. Филатова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Е. С. Филатова more than expected).

Fields of papers citing papers by Е. С. Филатова

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Е. С. Филатова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Е. С. Филатова. The network helps show where Е. С. Филатова may publish in the future.

Co-authorship network of co-authors of Е. С. Филатова

This figure shows the co-authorship network connecting the top 25 collaborators of Е. С. Филатова. A scholar is included among the top collaborators of Е. С. Филатова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Е. С. Филатова. Е. С. Филатова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Is fibromyalgia secondary to rheumatic diseases? 2025 ·Modern Rheumatology Journal ·E. G. Filatova,(unknown),Е. С. Филатова,А. М. Лила	0
2	Central sensitization reduces the satisfaction of patients with rheumatoid arthritis. The data of prospective study 2024 ·SHILAP Revista de lepidopterología ·(unknown),А. Е. Каратеев,(unknown),(unknown),Е. С. Филатова,(unknown),А. М. Лила	0
3	Olokizumab effect on chronic pain in rheumatoid arthritis: Results of the PROLOGUE observational study 2024 ·International Journal of Rheumatic Diseases ·А. Е. Каратеев,(unknown),Е. С. Филатова,(unknown),(unknown),А. М. Лила,А. А. Баранов,(unknown),(unknown)	0
4	Evaluation of the efficacy of complex analgesic therapy, including a combination of B vitamins, in patients with combination of osteoarthritis and chronic non-specific low back pain (results of an open-label pilot clinical trial) 2024 ·SHILAP Revista de lepidopterología ·Е. С. Филатова,А. Е. Каратеев,(unknown),(unknown),(unknown),А. М. Лила	2
5	Outcomes of the use of the glycosaminoglycan-peptide complex as monotherapy and in combination with diacerein for the treatment of knee osteoarthritis in real-world practice 2023 ·SHILAP Revista de lepidopterología ·А. Е. Каратеев,(unknown),(unknown),(unknown),Е. С. Филатова,С. И. Глухова,А. М. Лила	0
6	Features of clinical manifestations of rheumatoid arthritis in patients after failure of conventional synthetic disease-modifying antirheumatic drugs therapy depending on the signs of central sensitization 2023 ·SHILAP Revista de lepidopterología ·(unknown),А. Е. Каратеев,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Е. С. Филатова,(unknown),А. М. Лила	1
7	Need to assess the effect of therapy? Ask the patient! 2023 ·SHILAP Revista de lepidopterología ·(unknown),А. Е. Каратеев,(unknown),Е. С. Филатова,(unknown),(unknown),А. М. Лила	1
8	Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice? 2023 ·Doklady Biochemistry and Biophysics ·(unknown),А. Е. Каратеев,(unknown),Е. С. Филатова,(unknown),Mazurov Vi,(unknown),(unknown),А. А. Баранов,(unknown),А. М. Лила,Е. Л. Насонов	1
9	Comparison of classification criteria for giant cell arteritis 2023 ·Е. С. Филатова,N. Bulanov,(unknown),(unknown),(unknown),(unknown),(unknown),А. Yu. Suvorov,(unknown),А. В. Наумов,(unknown),Pavel Novikov,Sergey Moiseev	0
10	Are the goals of therapy achievable in patients with rheumatoid arthritis receiving upadacitinib in real clinical practice? 2022 ·SHILAP Revista de lepidopterología ·(unknown),А. Е. Каратеев,(unknown),Е. С. Филатова,(unknown),Mazurov Vi,(unknown),(unknown),А. А. Баранов,(unknown),А. М. Лила,Е. Л. Насонов	1
11	The Benefits of Family Screening in Rare Diseases: Genetic Testing Reveals 165 New Cases of Fabry Disease among At-Risk Family Members of 83 Index Patients 2022 ·Genes ·Sergey Moiseev,(unknown),(unknown),N. Bulanov,Е. С. Филатова,В. В. Фомин,Dominique P. Germain	11
12	Efficacy of combined use of glycosaminoglycan peptide complex for intramuscular administration and oral diacerein in osteoarthritis: evaluation according to an observational multicenter clinical trial 2021 ·Terapevticheskii arkhiv ·(unknown),Л. И. Алексеева,(unknown),(unknown),Е. С. Филатова,(unknown),А. М. Лила	6
13	Regular use of non-steroidal anti-inflammatory drugs can effectively control pain and global health in patients with moderate activity of rheumatoid arthritis 2021 ·SHILAP Revista de lepidopterología ·А. Е. Каратеев,(unknown),(unknown),Е. С. Филатова,(unknown)	2
14	An old friend: 25 years of meloxicam use in Russia. 2021 ·SHILAP Revista de lepidopterología ·А. Е. Каратеев,Е. Л. Насонов,(unknown),Е. С. Филатова,(unknown),(unknown)	1
15	Is there an alternative to diclofenac i/m injections for rapid relief of severe pain? Results of randomized controlled and partially blind forsage study 2020 ·SHILAP Revista de lepidopterología ·А. Е. Каратеев,(unknown),Е. С. Филатова,А. М. Лила,(unknown),(unknown)	1
16	Efficacy and safety of combination therapy with aceclofenac and pregabalin, compared with aceclofenac monotherapy for chronic pain in patients with osteoarthritis of the knee joints 2020 ·Фарматека ·Е. С. Филатова,(unknown),(unknown),(unknown),(unknown),А. М. Лила	0
17	Hyaluronic acid preparations in the treatment of osteoarthritis: is it clear to us? 2018 ·Modern Rheumatology Journal ·А. Е. Каратеев,(unknown),(unknown),Е. С. Филатова	3
18	Evaluation of the efficacy of pregabalin in the therapy of chronic pain in patients with knee osteoarthritis 2017 ·Terapevticheskii arkhiv ·Е. С. Филатова,(unknown),(unknown)	4
19	Central regulation of pain in patients with joint disease and approaches to therapy 2016 ·Terapevticheskii arkhiv ·Е. С. Филатова,Ш. Ф. Эрдес,E. G. Filatova	1
20	Carpal tunnel syndrome in rheumatic diseases 2015 ·SHILAP Revista de lepidopterología ·Е. С. Филатова	1

About Е. С. Филатова

Е. С. Филатова is a scholar working on Anatomy, Rheumatology and Pharmacology, having authored 51 papers that have together received 128 indexed citations. Recurring topics across this work include Fibromyalgia and Chronic Fatigue Syndrome Research (15 papers), Rheumatoid Arthritis Research and Therapies (15 papers) and Pain Mechanisms and Treatments (13 papers). The work is most often cited by research in Anatomy (4 citations), Psychiatry and Mental health (38 citations) and Rheumatology (37 citations). Е. С. Филатова has collaborated with scholars based in Russia, Czechia and United Kingdom. Frequent co-authors include А. М. Лила, А. Е. Каратеев, Л. И. Алексеева, Е. Л. Насонов, Ш. Ф. Эрдес, D Taylor‐Robinson, N. Bulanov, Dominique P. Germain, C A Ison and В. В. Фомин. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Genes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact